Argentine consensus on the clinical utility of breath tests and small intestinal bacterial overgrowth management in patients with disorders of gut-brain interaction.

Quick Summary

Twelve Argentine healthcare professionals met to develop consensus recommendations on using breath tests to diagnose small intestinal bacterial overgrowth (SIBO) in patients with gut-brain interaction disorders like IBS. Of 32 items discussed, 23 reached strong or relative agreement, supporting breath tests as safe and useful tools that should measure both hydrogen and methane gases.

What Was Studied

This was a formal consensus meeting held in Argentina to establish clinical guidelines on breath test use for diagnosing and managing intestinal microbial overgrowth in patients with disorders of gut-brain interaction (conditions where gut and brain communication is disrupted, like irritable bowel syndrome). The meeting aimed to address conceptual, technical, and clinical aspects of breath testing.

How the Study Was Conducted

Twelve healthcare professionals with experience in conducting breath tests and treating gut-brain interaction disorder patients participated in an in-person meeting. The group discussed and voted on 32 pre-selected items related to breath test methodology and interpretation. Full methodology not publicly available — summary based on abstract only.

Key Findings

• Breath tests were considered safe and useful for evaluating patients with gut-brain interaction disorders, including those with constipation-predominant IBS
• The panel recommended measuring both hydrogen and methane gases simultaneously, with a methane cutoff of ≥10 ppm for diagnosing intestinal methanogen overgrowth (excess methane-producing organisms)
• A flat-line pattern on breath tests was identified as potentially indicating sulfide overproduction, while elevated baseline hydrogen may reflect poor adherence to pre-test dietary preparation
• For patients with intestinal microbial overgrowth, rifaximin (a non-absorbable antibiotic) was recommended, and recording patient symptoms during testing was strongly encouraged